Integrase inhibitor use associated with weight gain in women and incident diabetes mellitus

Author(s):  
Archana Asundi ◽  
Alex J Olson ◽  
Wenqing Jiang ◽  
Swati P Varshney ◽  
Laura F White ◽  
...  
2021 ◽  
Author(s):  
Celestin Missikpode ◽  
Ramon Durazo-Arvizu ◽  
richard cooper ◽  
Matthew O'Brien ◽  
Sheila Castaneda ◽  
...  

Abstract Introduction Studies have reported an association between cardiovascular disease (CVD) and risk of diabetes mellitus (DM). The mechanisms underlying this association remain unclear. We examined the association of CVD with incident DM and assessed the roles of weight gain and medication use as mediating factors. Methods Data from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) Visit 1 (2008-2011) and Visit 2 (2014-2017) were used to compare incidence of DM among individuals with and without self-reported CVD at Visit 1. A total of 2081 individuals with self-reported CVD were matched to controls free of self-reported CVD at Visit 1 using 1:1 propensity score matching. Covariates included in the propensity model were sociodemographic characteristics, lifestyle factors, comorbid conditions, and study site. The effect of self-reported CVD on incident DM was examined using Generalized Estimating Equation. The mediating effects of weight gain and use of cardiovascular medications were evaluated. ResultsCovariate distributions were similar among individuals with and without self-reported CVD. The incidence of DM among persons with self-reported CVD was 15.6% vs. 12.7% among those without self-reported CVD. Compared to individuals without self-reported CVD, individuals with self-reported CVD had a 28% increased risk for incident DM (OR=1.28, 95%CI= 1.07, 1.52). The association between self-reported CVD and DM was mediated by the use of beta-blockers (proportion mediated=31%), statins (proportion mediated=24%), and diuretics (proportion mediated=8%). We found that weight gain did not explain the observed association.ConclusionsCardiovascular disease was associated with a significant increased risk of incident diabetes. The observed association was partially mediated by some medications used to manage CVD.


2010 ◽  
Vol 95 (8) ◽  
pp. 3578-3585 ◽  
Author(s):  
Jennifer Hone ◽  
Lois Jovanovič

The epidemics of obesity and type 2 diabetes mellitus (T2DM) globally are paralleling an increase in the number of women with T2DM becoming pregnant. Because T2DM is frequently undiagnosed before pregnancy, the risk of major malformations in the developing fetus is increased due to uncontrolled hyperglycemia. The lack of preconception care and the increase in complications of pregnancy due to the coexistence of obesity and T2DM are of concern from both an individual and a public health standpoint. Rapid achievement of normoglycemia with limited weight gain is critical to optimize maternal and fetal outcomes in all women with diabetes during pregnancy, regardless of the type of diabetes. This article will focus on T2DM preceding pregnancy due to its increasing prevalence and potentially dire fetal and maternal consequences. Euglycemia before, during, and after all pregnancies complicated by diabetes results in the best opportunity for optimal outcomes for mother and infant.


2015 ◽  
Vol 212 (1) ◽  
pp. S229
Author(s):  
Amy O'Higgins ◽  
Lisa O'Higgins ◽  
Anne Fennessy ◽  
Thomas McCartan ◽  
Laura Mullaney ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document